retatrutide triple agonist gip glp-1 glucagon phase 2 obesity trial Medscape | The investigational GLP-1/GIP/glucagon receptor produced significant weight loss and A1c reduction in people A review of an investigational
Pay in 4 interest-free payments of $5.66 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5





















